An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging virus that
has caused the recent coronavirus disease (COVID-19) global pandemic. The current …
has caused the recent coronavirus disease (COVID-19) global pandemic. The current …
Progress and prospects on vaccine development against monkeypox infection
The monkeypox virus (MPOX) is an uncommon zoonotic illness brought on by an
orthopoxvirus (OPXV). MPOX can occur with symptoms similar to smallpox. Since April 25 …
orthopoxvirus (OPXV). MPOX can occur with symptoms similar to smallpox. Since April 25 …
Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates
M Prabhakaran, F Matassoli, D Leggat… - Science Translational …, 2024 - science.org
Durable humoral immunity is mediated by long-lived plasma cells (LLPCs) that reside in the
bone marrow. It remains unclear whether severe acute respiratory syndrome coronavirus 2 …
bone marrow. It remains unclear whether severe acute respiratory syndrome coronavirus 2 …
Safety and immunogenicity of a SARS-CoV-2 Gamma variant RBD-based protein adjuvanted vaccine used as booster in healthy adults
KA Pasquevich, LM Coria, A Ceballos… - Nature …, 2023 - nature.com
Abstract A Gamma Variant RBD-based aluminum hydroxide adjuvanted vaccine called
ARVAC CG was selected for a first in human clinical trial. Healthy male and female …
ARVAC CG was selected for a first in human clinical trial. Healthy male and female …
Development in the concept of bacterial polysaccharide repeating unit-based antibacterial conjugate vaccines
R Rohokale, Z Guo - ACS infectious diseases, 2023 - ACS Publications
The surface of cells is coated with a dense layer of glycans, known as the cell glycocalyx.
The complex glycans in the glycocalyx are involved in various biological events, such as …
The complex glycans in the glycocalyx are involved in various biological events, such as …
Therapeutic and diagnostic applications of nanoparticles in the management of COVID-19: a comprehensive overview
Abstract In December 2019, Coronavirus Disease 2019 (COVID-19) was reported in Wuhan,
China. Comprehensive strategies for quick identification, prevention, control, and remedy of …
China. Comprehensive strategies for quick identification, prevention, control, and remedy of …
A phase 3, randomised, double-blind, placebo-controlled clinical trial evaluation of the efficacy and safety of a SARS-CoV-2 recombinant spike RBD protein vaccine in …
F Hernández-Bernal, MC Ricardo-Cobas… - The Lancet Regional …, 2023 - thelancet.com
Background The pandemic of COVID-19 raised the urgent need for safe and efficacious
vaccines against SARS-CoV-2. We evaluated the efficacy and safety of a new SARS-CoV-2 …
vaccines against SARS-CoV-2. We evaluated the efficacy and safety of a new SARS-CoV-2 …
Epidemic history and evolution of an emerging threat of international concern, the severe acute respiratory syndrome coronavirus 2
This comprehensive review focuses on the severe acute respiratory syndrome coronavirus 2
(SARS‐CoV‐2) and its impact as the cause of the COVID‐19 pandemic. Its objective is to …
(SARS‐CoV‐2) and its impact as the cause of the COVID‐19 pandemic. Its objective is to …
Q fever immunology: the quest for a safe and effective vaccine
Q fever is an infectious zoonotic disease, caused by the Gram-negative bacterium Coxiella
burnetii. Transmission occurs from livestock to humans through inhalation of a survival form …
burnetii. Transmission occurs from livestock to humans through inhalation of a survival form …
Protein subunit vaccines: Promising frontiers against COVID-19
The emergence of COVID-19 has posed an unprecedented global health crisis, challenging
the healthcare systems worldwide. Amidst the rapid development of several vaccine …
the healthcare systems worldwide. Amidst the rapid development of several vaccine …